Strategic niche Elicityl specializes in carbohydrates design and manufacturing with capabilities spanning extraction, purification, bacterial fermentation, and detailed characterization, enabling tailored carbohydrate solutions for biotech, medical devices, and agriculture sectors that align with growing glycoscience demand.

Biomass to glycans With a pilot plant for semi-industrial carbohydrate production from biomass and a robust biofermentation platform hosting over 150 bacterial strains, there is an opportunity to scale custom HMOs, glycoconjugates, and functionalized glycans for research collaborations or supply agreements.

Analytical edge A comprehensive analytical suite including HPAEC-PAD, HPLC-ELSD, 1H/13C NMR, and MS enables joint development programs for complex glycans, targeting customers needing advanced characterization for quality control, regulatory submissions, or product development.

Application reach Current focus areas—plant protection, animal nutrition, anti-infectious compounds, and medical devices—present cross-industry sales opportunities to partners seeking specialized glycans, lectins, and glycoconjugates to enhance performance and safety.

Growth catalysts Smaller biotech players and research labs in Europe seeking cost-effective, customized glycan solutions could benefit from Elicityl’s end-to-end services and scale-ready capabilities, suggesting targeted outreach for R&D collaborations, supply contracts, or white-label opportunities.